Editorial | Published:

Into the 21st Century

Bio/Technologyvolume 11pagesS16S20 (1993) | Download Citation

Subjects

Biotechnology and pharmaceutical industry in the next ten years

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Avery, O.T. et al. 1944. J.Exp. Med. 79: 137–158.

  2. 2

    Watson, J.D. and Crick, F.H.C. 1953. Nature 171: 737–738.

  3. 3

    Drews, J. 1992. Scientific Paradigms in Medicine. Editiones Roche, Basel.

  4. 4

    Cohen, S.N. et al. 1973. Proc. Natl. Acad. Sci. USA 70: 3240–3244.

  5. 5

    Drews, J. 1989. Drug News and Perspectives 2: 453–460.

  6. 6

    Jones, P.T., et al. 1986. Nature 321: 522–525. Reichmann, L., et al. 1988. Nature 332: 323–329.

  7. 7

    Daniel, M.D. et al. 1992. Science 258: 1938–1941.

  8. 8

    Lesslauer, W. et al. 1991. Eur. J. Immunol. 21: 2883–2886.

  9. 9

    Prous, J.R. 1991. Drug News and Perspectives 4: 96–109.

  10. 10

    Burrill, S. and Lee, K.B. Jr. 1992. Biotech 1993. Accelerating Commercialization. Ernst and Young, San Francisco.

  11. 11

    Drews, J. 1990. Pharm Weekbl Sci. 12: 6–10.

  12. 12

    Popper, K. 1964. The Poverty of Historicism. Newark and Evanston (Harper Torchbook), New York.

Download references

Author information

Author notes

  1. Jürgen Drews, M.D.,is president for international research and development at Hoffmann-La Roche. He can be reached through Hoffmann-La Roche, 340 Kingsland St., Nutley, New Jersey 07110-1199.

    • Jürgen Drews

Authors

  1. Search for Jürgen Drews in:

About this article

Publication history

Issue Date

DOI

https://doi.org/10.1038/nbt0393-S16

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing